These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 18502680)

  • 21. Molecular and functional interactions between tumor necrosis factor-alpha receptors and the glutamatergic system in the mouse hippocampus: implications for seizure susceptibility.
    Balosso S; Ravizza T; Pierucci M; Calcagno E; Invernizzi R; Di Giovanni G; Esposito E; Vezzani A
    Neuroscience; 2009 Jun; 161(1):293-300. PubMed ID: 19285115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The membrane form of tumor necrosis factor is sufficient to mediate partial innate immunity to Francisella tularensis live vaccine strain.
    Cowley SC; Goldberg MF; Ho JA; Elkins KL
    J Infect Dis; 2008 Jul; 198(2):284-92. PubMed ID: 18593295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intragraft TNF receptor signaling contributes to activation of innate and adaptive immunity in a renal allograft model.
    Hummel M; Kurian SM; Lin S; Borodyanskiy A; Zhang Z; Li Z; Kim SJ; Salomon DR; Abecassis M
    Transplantation; 2009 Jan; 87(2):178-88. PubMed ID: 19155971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Bcl-2 family in autoimmune and degenerative disorders.
    Mérino D; Bouillet P
    Apoptosis; 2009 Apr; 14(4):570-83. PubMed ID: 19172396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TNF-alpha in nucleus pulposus induces sensory nerve growth: a study of the mechanism of discogenic low back pain using TNF-alpha-deficient mice.
    Hayashi S; Taira A; Inoue G; Koshi T; Ito T; Yamashita M; Yamauchi K; Suzuki M; Takahashi K; Ohtori S
    Spine (Phila Pa 1976); 2008 Jun; 33(14):1542-6. PubMed ID: 18552668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoimmune diseases induced by TNF-targeted therapies.
    Ramos-Casals M; Brito-Zerón P; Soto MJ; Cuadrado MJ; Khamashta MA
    Best Pract Res Clin Rheumatol; 2008 Oct; 22(5):847-61. PubMed ID: 19028367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor necrosis factor-alpha modulates survival, proliferation, and neuronal differentiation in neonatal subventricular zone cell cultures.
    Bernardino L; Agasse F; Silva B; Ferreira R; Grade S; Malva JO
    Stem Cells; 2008 Sep; 26(9):2361-71. PubMed ID: 18583543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-TNF-induced lupus.
    Williams EL; Gadola S; Edwards CJ
    Rheumatology (Oxford); 2009 Jul; 48(7):716-20. PubMed ID: 19416947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene targeting methods for studying nuclear transport factors in mice.
    Dawlaty MM; van Deursen JM
    Methods; 2006 Aug; 39(4):370-8. PubMed ID: 16887365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased behavioral impairments in an Alzheimer mice model by interfering with TNF-alpha metabolism.
    Giuliani F; Vernay A; Leuba G; Schenk F
    Brain Res Bull; 2009 Oct; 80(4-5):302-8. PubMed ID: 19622386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-function relationship of tumor necrosis factor (TNF) and its receptor interaction based on 3D structural analysis of a fully active TNFR1-selective TNF mutant.
    Mukai Y; Shibata H; Nakamura T; Yoshioka Y; Abe Y; Nomura T; Taniai M; Ohta T; Ikemizu S; Nakagawa S; Tsunoda S; Kamada H; Yamagata Y; Tsutsumi Y
    J Mol Biol; 2009 Jan; 385(4):1221-9. PubMed ID: 19084540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MKK4 is a novel target for the inhibition of tumor necrosis factor-alpha-induced vascular endothelial growth factor expression by myricetin.
    Kim JE; Kwon JY; Lee DE; Kang NJ; Heo YS; Lee KW; Lee HJ
    Biochem Pharmacol; 2009 Feb; 77(3):412-21. PubMed ID: 19026990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergism of toll-like receptor 2 (TLR2), TLR4, and TLR6 ligation on the production of tumor necrosis factor (TNF)-alpha in a spontaneous arthritis animal model of interleukin (IL)-1 receptor antagonist-deficient mice.
    Jung YO; Cho ML; Lee SY; Oh HJ; Park JS; Park MK; Park MJ; Ju JH; Kim SI; Park SH; Kim HY; Min JK
    Immunol Lett; 2009 Apr; 123(2):138-43. PubMed ID: 19428561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mouse models of altered protein kinase A signaling.
    Kirschner LS; Yin Z; Jones GN; Mahoney E
    Endocr Relat Cancer; 2009 Sep; 16(3):773-93. PubMed ID: 19470615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene targeting in immunology.
    Totey SM; Kulkarni AB
    Indian J Exp Biol; 2000 Aug; 38(8):733-45. PubMed ID: 12557903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Appearances can be deceiving: phenotypes of knockout mice.
    Barbaric I; Miller G; Dear TN
    Brief Funct Genomic Proteomic; 2007 Jun; 6(2):91-103. PubMed ID: 17584761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissection of the pathologies induced by transmembrane and wild-type tumor necrosis factor in transgenic mice.
    Probert L; Akassoglou K; Alexopoulou L; Douni E; Haralambous S; Hill S; Kassiotis G; Kontoyiannis D; Pasparakis M; Plows D; Kollias G
    J Leukoc Biol; 1996 Apr; 59(4):518-25. PubMed ID: 8613699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can we design a better anti-cytokine therapy?
    Drutskaya MS; Efimov GA; Kruglov AA; Nedospasov SA
    J Leukoc Biol; 2017 Sep; 102(3):783-790. PubMed ID: 28546502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TNF-alpha in promotion and progression of cancer.
    Balkwill F
    Cancer Metastasis Rev; 2006 Sep; 25(3):409-16. PubMed ID: 16951987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycosphingolipid functions: insights from engineered mouse models.
    Proia RL
    Philos Trans R Soc Lond B Biol Sci; 2003 May; 358(1433):879-83. PubMed ID: 12803921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.